CHRS CIK: 1512762

Coherus Oncology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−37.4
FY22:
−241
FY23:
−175
FY24:
−20.4
FY25:
−139
Change from FY21 to FY25
millions USD
FY21:
−138
FY22:
−167
FY23:
145
FY24:
230
FY25:
375
Change from FY21 to FY25
millions USD
FY21:
51.9
FY22:
54.3
FY23:
69.6
FY24:
−187
FY25:
−274
millions USD
FY21:
−124
FY22:
−354
FY23:
39.4
FY24:
22.9
FY25:
−37.1
(positive)
Change from FY21 to FY23
millions USD
FY21:
−38.7
FY22:
−243
FY23:
−175
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR